FDA Approves Boostrix for Third-Trimester Administration
Approval is specifically for use during pregnancy to prevent pertussis in infants whose mothers are vaccinated during pregnancy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.